Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingbugongxia Prescription for sepsis with lung and stomach heat syndrome
ChiCTR-IIR-16009140Phase 2Not yet recruiting
- Sponsor
- Tianjin First Central Hospital
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Qingbugongxia in sepsis (2 arms), sponsored by Tianjin First Central Hospital. Primary endpoints: Complete blood count, Blood biochemistry and 5 more. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
Qingbugongxia
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR-IIR-16009140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16009140.